Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
11/11/2019 Experts to gather in Africa to speed up development of vaccines to prevent bacterial infections
25/10/2019 Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation
Posted 11 November 2019 Experts to gather in Africa to speed up development of vaccines to prevent bacterial infections A global network of scientists who are working together to accelerate the development of vaccines against bacterial infections in low and middle income countries are to stage an annual network meeting in Africa.
Posted 30 October 2019 New collaborative learning hub helps bridge the gap between medicine and engineering The Clinician Engineer Hub aims to educate medical students and early career doctors about the diagnostic and treatment challenges in clinical medicine.
Posted 29 October 2019 Senior Clinical Lecturer joins Institute of Immunology and Immunotherapy Dr Leila Khoja joins Birmingham from AstraZeneca and Addenbrooke's Hospital, bringing with her an extensive experience in translating immunotherapies from bench to bedside.
Posted 25 October 2019 Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation Researchers at the University of Birmingham awarded £1.15 million for latest equipment for immune regulation.
Posted 03 October 2019 New partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.
Posted 27 August 2019 Removing cancer's protective barrier could boost immunotherapy treatments University of Birmingham scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments.